Randomized controlled trial of a multiple technology-based physical activity intervention for Latina adolescents: Recruitment strategies and baseline data from the Chicas Fuertes trial
Jeanean B. Naqvi , Brittany Olesen , Emily Greenstadt , Jacob Carson , Bess Marcus , Job Godino , Michelle Zive , Dawn Meyer , Michael Higgins , Lilliana Osuna , Rubi Gomez , Shira Dunsiger , Britta Larsen
{"title":"Randomized controlled trial of a multiple technology-based physical activity intervention for Latina adolescents: Recruitment strategies and baseline data from the Chicas Fuertes trial","authors":"Jeanean B. Naqvi , Brittany Olesen , Emily Greenstadt , Jacob Carson , Bess Marcus , Job Godino , Michelle Zive , Dawn Meyer , Michael Higgins , Lilliana Osuna , Rubi Gomez , Shira Dunsiger , Britta Larsen","doi":"10.1016/j.cct.2024.107716","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Latina adolescents report low levels of physical activity (PA) and high lifetime risk of lifestyle-related diseases. They also have high rates of using technology, suggesting interventions delivered through mobile devices may be effective for this population. The current paper describes recruitment methods and baseline study characteristics for <em>Chicas Fuertes</em>, a fully powered randomized trial of a mobile technology PA intervention.</div></div><div><h3>Methods</h3><div>Underactive Latina adolescents (aged 13–18) were recruited using social media and presentations at local schools and community organizations in San Diego, California. Participants were randomly assigned 1:1 to either the intervention (Fitbit, tailored texting, social media, and website) or control group. Baseline measures included demographics, psychosocial variables, and PA measured by the 7-Day Physical Activity Recall (PAR), ActiGraph GT3X+ accelerometers, and Fitbits. Baseline data were collected from 2020 to 2023.</div></div><div><h3>Results</h3><div>Social media yielded the most contacts (465), but had the lowest chance of enrollment (14 %, vs. 52 % from school presentations). Participants (<em>N</em> = 160) were mostly second generation (68.8 %), and low income (61.8 %), but technology access was high (>99 %). Median self-reported moderate-to-vigorous PA (MVPA) using the 7-Day PAR was 120 min/week (range 0–720), and median daily steps were 5222 (IQR 359). Median MVPA measured by ActiGraphs, however, was 0 min per week<strong>.</strong> There was no correlation between the 7-day PAR and ActiGraphs (<span><math><mi>ρ</mi><mo>=</mo><mn>.13</mn><mo>,</mo><mi>p</mi><mo>=</mo><mn>.12</mn><mo>)</mo></math></span>. However, ActiGraph MVPA was correlated with total steps recorded by the Fitbit (<span><math><mi>ρ</mi><mo>=</mo><mn>.38</mn><mo>,</mo><mi>p</mi><mo><</mo><mn>.001</mn></math></span>).</div></div><div><h3>Conclusions</h3><div>Both remote and in-person approaches were successful in recruiting a sample that was underactive and low income, but had high technology use.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"147 ","pages":"Article 107716"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714424002994","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Latina adolescents report low levels of physical activity (PA) and high lifetime risk of lifestyle-related diseases. They also have high rates of using technology, suggesting interventions delivered through mobile devices may be effective for this population. The current paper describes recruitment methods and baseline study characteristics for Chicas Fuertes, a fully powered randomized trial of a mobile technology PA intervention.
Methods
Underactive Latina adolescents (aged 13–18) were recruited using social media and presentations at local schools and community organizations in San Diego, California. Participants were randomly assigned 1:1 to either the intervention (Fitbit, tailored texting, social media, and website) or control group. Baseline measures included demographics, psychosocial variables, and PA measured by the 7-Day Physical Activity Recall (PAR), ActiGraph GT3X+ accelerometers, and Fitbits. Baseline data were collected from 2020 to 2023.
Results
Social media yielded the most contacts (465), but had the lowest chance of enrollment (14 %, vs. 52 % from school presentations). Participants (N = 160) were mostly second generation (68.8 %), and low income (61.8 %), but technology access was high (>99 %). Median self-reported moderate-to-vigorous PA (MVPA) using the 7-Day PAR was 120 min/week (range 0–720), and median daily steps were 5222 (IQR 359). Median MVPA measured by ActiGraphs, however, was 0 min per week. There was no correlation between the 7-day PAR and ActiGraphs (. However, ActiGraph MVPA was correlated with total steps recorded by the Fitbit ().
Conclusions
Both remote and in-person approaches were successful in recruiting a sample that was underactive and low income, but had high technology use.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.